ANAGRELIDE - A POTENT AND SELECTIVE INHIBITOR OF PLATELET CYCLIC-AMP PHOSPHODIESTERASE ENZYME-ACTIVITY

被引:49
作者
GILLESPIE, E
机构
关键词
D O I
10.1016/0006-2952(88)90054-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:2866 / 2868
页数:3
相关论文
共 14 条
[1]   CARDIOTONIC ACTIVITY OF MILRINONE, A NEW AND POTENT CARDIAC BIPYRIDINE, ON THE NORMAL AND FAILING HEART OF EXPERIMENTAL-ANIMALS [J].
ALOUSI, AA ;
CANTER, JM ;
MONTENARO, MJ ;
FORT, DJ ;
FERRARI, RA .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (05) :792-803
[2]   EVALUATION OF A NEW BIPYRIDINE INOTROPIC AGENT - MILRINONE - IN PATIENTS WITH SEVERE CONGESTIVE HEART-FAILURE [J].
BAIM, DS ;
MCDOWELL, AV ;
CHERNILES, J ;
MONRAD, ES ;
PARKER, JA ;
EDELSON, J ;
BRAUNWALD, E ;
GROSSMAN, W .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (13) :748-756
[3]   POTENT NEW INHIBITOR OF PLATELET-AGGREGATION AND EXPERIMENTAL THROMBOSIS, ANAGRELIDE (BL-4162A) [J].
FLEMING, JS ;
BUYNISKI, JP .
THROMBOSIS RESEARCH, 1979, 15 (3-4) :373-388
[4]  
FLEMING JS, 1983, NEW DRUGS ANN CARDIO, P277
[5]   PURIFICATION AND CHARACTERIZATION OF A HUMAN-PLATELET CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE [J].
GRANT, PG ;
COLMAN, RW .
BIOCHEMISTRY, 1984, 23 (08) :1801-1807
[6]  
KASTNER PR, 1985, FED PROC, V44, P716
[7]   IMMUNOLOGICAL IDENTIFICATION OF THE MAJOR PLATELET LOW-KM CAMP PHOSPHODIESTERASE - PROBABLE TARGET FOR ANTITHROMBOTIC AGENTS [J].
MACPHEE, CH ;
HARRISON, SA ;
BEAVO, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (17) :6660-6663
[8]   PURIFICATION AND PROPERTIES OF THE INSULIN-STIMULATED CYCLIC-AMP PHOSPHODIESTERASE FROM RAT-LIVER PLASMA-MEMBRANES [J].
MARCHMONT, RJ ;
AYAD, SR ;
HOUSLAY, MD .
BIOCHEMICAL JOURNAL, 1981, 195 (03) :645-652
[9]   THE IDENTIFICATION OF A NEW CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY IN HUMAN AND GUINEA-PIG CARDIAC VENTRICLE - IMPLICATIONS FOR THE MECHANISM OF ACTION OF SELECTIVE PHOSPHODIESTERASE INHIBITORS [J].
REEVES, ML ;
LEIGH, BK ;
ENGLAND, PJ .
BIOCHEMICAL JOURNAL, 1987, 241 (02) :535-541
[10]  
TANG SS, 1980, J LAB CLIN MED, V95, P241